Thiobenzoic Acid

Thiobenzoic Acid

SCHEMBL7584058

Cc1ccccc1.O=[N+]([O-])c1ccc(C(O)=S)cc1.OC(=S)c1ccccc1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.59
CES2 O00748 1/20 0.59
ACHE P22303 1/20 0.55
HSD17B10 Q99714 1/20 0.55
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
GAA P10253 2/20 0.51
MAPK1 P28482 4/20 0.50
POLB P06746 3/20 0.50
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 4/20 0.48
LMNA P02545 4/20 0.48
HPGD P15428 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
NPC1 O15118 1/20 0.47
MITF O75030 1/20 0.47
RAB9A P51151 1/20 0.47
MAOA P21397 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Nitrotoluene SCHEMBL23112224 0.93 ACHE (0.60) CES1CES2ACHEHSD17B10MEN1
4-Nitrotoluene SCHEMBL21633328 0.90 ACHE (0.51) CES1CES2ACHEHSD17B10MEN1
SCHEMBL7520487 0.86 TDP1 (0.65) CES1CES2MEN1KMT2AGAA
SCHEMBL10621948 0.84 TDP1 (0.63) CES1CES2MEN1KMT2AGAA
Thiobenzoic Acid SCHEMBL8579917 0.83 CES2 (0.54) CES1CES2MEN1KMT2AGAA
4-Nitrobenzoyl Chloride SCHEMBL27648131 0.80 ALDH1A1 (0.73) CES1CES2ACHEHSD17B10MEN1
SCHEMBL20120205 0.80 ACHE (0.78) CES1CES2ACHEHSD17B10MEN1
Nitrobenzene SCHEMBL4937722 0.80 LMNA (0.76) CES1CES2ACHEHSD17B10MEN1
Thiobenzoic Acid SCHEMBL28198923 0.80 LMNA (0.58) CES1CES2ACHEMEN1KMT2A
Thiobenzoic Acid SCHEMBL7582715 0.78 CES2 (0.56) CES1CES2ACHEMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458968-B2 REACTING A CARBOXYLIC ACID COMPOUND WITH AN ALCOHOL OR MERCAPTAN, THEN PHOSPHORUS PENTASULFIDE RENSSELAER POLYTECHNIC INSTITUTE 2002-10-01 US claimed
US-20020019554-A1 Dithiocarboxylic ester synthetic process RENSSELAER POLYTECHNIC INSTITUTE 2002-02-14 US claimed
US-6458968-B2 REACTING A CARBOXYLIC ACID COMPOUND WITH AN ALCOHOL OR MERCAPTAN, THEN PHOSPHORUS PENTASULFIDE RENSSELAER POLYTECHNIC INSTITUTE 2002-10-01 US disclosed
US-20020019554-A1 Dithiocarboxylic ester synthetic process RENSSELAER POLYTECHNIC INSTITUTE 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019554-A1 Dithiocarboxylic ester synthetic process TST, PCCA, CTH CES1 737/4885CES2 1778/4885ACHE 3128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.